Literature DB >> 16966017

Lupus erythematosus: systemic and cutaneous manifestations.

Naomi Rothfield1, Richard D Sontheimer, Megan Bernstein.   

Abstract

Skin and joint involvements are the most commonly occurring manifestations of systemic lupus erythematosus. There are 3 forms of cutaneous lupus: chronic cutaneous (discoid) lupus, subacute cutaneous lupus, and acute cutaneous lupus. Joint manifestations are usually not associated with warmth of the joints and may be only associated with pain and swelling. Painful or swollen joints respond rapidly to small or moderate doses of corticosteroids, whereas cutaneous manifestations usually respond to antimalarial drugs. Anti-Ro is associated closely with a photosensitive rash and with subacute lupus.

Entities:  

Mesh:

Year:  2006        PMID: 16966017     DOI: 10.1016/j.clindermatol.2006.07.014

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  43 in total

1.  Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.

Authors:  Elizabeth A Mauldin; Daniel O Morris; Dorothy C Brown; Margret L Casal
Journal:  Vet Dermatol       Date:  2010-04-01       Impact factor: 1.589

Review 2.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

3.  Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon.

Authors:  Samuel Katsuyuki Shinjo; Eloísa Bonfá
Journal:  Clin Rheumatol       Date:  2010-03-28       Impact factor: 2.980

Review 4.  The Cutaneous Spectrum of Lupus Erythematosus.

Authors:  Simone Ribero; Savino Sciascia; Luca Borradori; Dan Lipsker
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

5.  Response letter to 'chronic cutaneous lupus erythematosus induced by 5-fluorouracil'.

Authors:  Robert Borucki; Victoria P Werth
Journal:  Expert Rev Clin Pharmacol       Date:  2020-07-17       Impact factor: 5.045

6.  Is there a difference in systemic lupus erythematosus with and without Raynaud's phenomenon?

Authors:  Slavica Pavlov-Dolijanovic; Nemanja S Damjanov; Nada Z Vujasinovic Stupar; Danijel R Marcetic; Mirjana N Sefik-Bukilica; Radmila R Petrovic
Journal:  Rheumatol Int       Date:  2012-05-22       Impact factor: 2.631

7.  Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus.

Authors:  Zaixing Yang; Yan Liang; Chang Li; Weiqiang Xi; Renqian Zhong
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

Review 8.  Cutaneous lupus erythematosus: diagnosis and treatment.

Authors:  L G Okon; V P Werth
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-06       Impact factor: 4.098

9.  Demographic and clinical characteristics of cutaneous lupus erythematosus at a paediatric dermatology referral centre.

Authors:  B Z Dickey; K E Holland; B A Drolet; S S Galbraith; V B Lyon; D H Siegel; Y E Chiu
Journal:  Br J Dermatol       Date:  2013-08       Impact factor: 9.302

10.  European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.

Authors:  M Mosca; C Tani; M Aringer; S Bombardieri; D Boumpas; R Brey; R Cervera; A Doria; D Jayne; M A Khamashta; A Kuhn; C Gordon; M Petri; O P Rekvig; M Schneider; Y Sherer; Y Shoenfeld; J S Smolen; R Talarico; A Tincani; R F van Vollenhoven; M M Ward; V P Werth; L Carmona
Journal:  Ann Rheum Dis       Date:  2009-11-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.